Lab business > Distributorships & acquisitions

BioAgilytix to purchase Australia's 360biolabs

23 August, 2021

BioAgilytix Labs describes 360biolabs as the most comprehensive contract research organisation in Australia.


Teledyne completes acquisition of FLIR Systems

27 May, 2021

FLIR Systems will now be included in Teledyne Technologies' Digital Imaging segment and operate under the name Teledyne FLIR.


Trajan acquires blood testing business MyHealthTest

22 April, 2021

Trajan Scientific and Medical has completed its acquisition of the MyHealthTest blood testing service for an undisclosed sum.


Vidrio Technologies acquired by MBF Bioscience

14 April, 2021

MBF Bioscience is expanding its two-photon and laser scanning technology capabilities by acquiring Vidrio Technologies.


Thermo Fisher acquires Mesa Biotech, Novasep's Henogen

20 January, 2021

Thermo Fisher Scientific has entered into a definitive agreement to acquire Mesa Biotech and completed its acquisition of Henogen.


Distribution agreement should reduce kidney injury in A/NZ

14 October, 2020

Regional Health Care Group (RHCG) will distribute Osprey Medical's DyeVert contrast minimisation devices across Australia and New Zealand for the first time.


Illumina to acquire cancer detection company GRAIL

06 October, 2020

Illumina has entered into a definitive agreement to acquire GRAIL — a healthcare company whose mission is focused on multi-cancer early detection.


Inflammation start-up acquired by Roche

01 October, 2020

Inflazome, based on a research partnership between The University of Queensland and Trinity College Dublin, has been acquired for an upfront cash payment of €380m.


Illumina acquires Enancio's compression software

22 July, 2020

Illumina has a new addition to its portfolio: genomic compression-software company Enancio, based in Cesson-Sévigné, France.


Metrohm named exclusive Aus distributor of ELGA water purification products

09 March, 2020

Metrohm Australia has announced that, as of 1 March 2020, it is the exclusive distributor for ELGA LabWater in Australia for the PURELAB and CENTRA ranges.


Abcam purchases assets from Applied StemCell

10 February, 2020

Abcam has announced the asset purchase of the gene editing platform and oncology product portfolio of Applied StemCell for life science research and diagnostic markets.


Abcam acquires Expedeon's Proteomics and Immunology business

17 January, 2020

Abcam has announced the successful completion of the acquisition of Expedeon's Proteomics and Immunology business, which includes Innova and TGR Biosciences, as of 1 January 2020.


AXT adds Alvéole's cell biology platform to its portfolio

06 December, 2019

The Alvéole platform allows users to convert an existing microscope into an automated bioengineering system for the engineering of smart cell culture substrates.


Abcam acquires live cells and lysates from EdiGene

26 July, 2019

Abcam has announced its acquisition of the entire live cell line and lysates portfolio of EdiGene, a Chinese company focused on developing genome editing technologies into novel therapeutics.


Agilent expands cell analysis portfolio with BioTek acquisition

19 July, 2019

Agilent Technologies has signed a definitive agreement to acquire the privately owned BioTek Instruments for $1.165 billion.


  • All content Copyright © 2021 Westwick-Farrow Pty Ltd